Skip to main content

Find Clinical Trials

Home
Conditions
Mucopolysaccharidosis VI

Clinical trial condition

Mucopolysaccharidosis VI

Explore clinical trials studying Mucopolysaccharidosis VI. Study availability and eligibility vary by location and protocol.

27 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Mucopolysaccharidosis VI trial results

Completed

Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI

NCT00067470

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +9 more
Locations: BioMarin Pharmaceutical Inc. Novato, California, United States

View Trial Details

Completed

Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI

NCT00048711

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +9 more
Locations: BioMarin Pharmaceutical Inc. Novato, California, United States

View Trial Details

Completed

Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI

NCT00048620

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +9 more
Locations: BioMarin Pharmaceutical Inc. Novato, California, United States

View Trial Details

Active, Not Recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions: 17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations: RTI International Research Triangle Park, North Carolina, United States

View Trial Details

Active, Not Recruiting

Safety and Efficacy of Voxzogo for Growth Deficits in MPS IVA and VI

NCT05845749

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +12 more
Locations: UCSF Benioff Children's Hospital Oakland Oakland, California, United States

View Trial Details

Active, Not Recruiting

Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI

NCT03153319

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +18 more
Locations: The Lundquist Institute at Harbor-UCLA Medical Center Torrance, California, United States

View Trial Details

Active, Not Recruiting

MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis

NCT02171104

Conditions: Abnormalities, Multiple, Acyl-CoA Oxidase Deficiency, Adrenoleukodystrophy With Cerebral Involvement, +85 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details